Seeking Alpha

Seeking Alpha Portfolio App for iPad

Timeless Wealth

Timeless Wealth picture

Timeless Wealth

Profile

Send Message

View as an RSS Feed

View Timeless Wealth's Articles BY TICKER:

The $15 Billion Patent-Play In Trovagene
on Wed, Dec 12, 2012 • TROV • 15 Comments
Ex-Rabbi Turned Investment Manager Spots Information Arbitrage In These 2 Companies
on Tue, Nov 27, 2012 • ARNA, BAX, GPN • 12 Comments
Trovagene Poised To Lead The Next Generation Of Molecular Diagnostics Technology
on Thu, Jun 28, 2012 • ABT, BDX, GPRO • 2 Comments
What This News Means For Healthcare Stocks
on Tue, Jun 19, 2012 • MDVN, RIGL, BPAX • Comment!
Repros Therapeutics: More Holes Than A Block Of Swiss Cheese
on Tue, Jun 5, 2012 • ABT, ARUXF.PK, AUXL • 7 Comments
Institutional Investors Bet On Prolor, Synergy, Arena Pharmaceuticals
on Tue, May 22, 2012 • IRWD, PBTH, TEVA • 5 Comments
4 Healthcare Stocks Breaking Out Mid-Week
on Thu, May 3, 2012 • ALXA, AMRN, DNDN • Comment!
NovaBay: Tomorrow's Staple In Antimicrobial Therapy?
on Wed, May 2, 2012 • CTIC, NBS, OCLS • 2 Comments
Reading Into Prolor's Technology Offering: Major Partnership On The Horizon
on Mon, Apr 16, 2012 • HALO, MRK, NVO • Comment!
Oculus: Financial Distress, Concentration Risk, And Other Red Flags
on Thu, Mar 22, 2012 • OCLS • 12 Comments
Ampio Shares To Rise In Advance Of Optina Data
on Tue, Mar 20, 2012 • RHHBY.OB, AMPE • Comment!
How Qnexa's Positive Panel Review Generated Alpha For Short Sellers
on Thu, Feb 23, 2012 • ARNA, OREX, VVUS • 14 Comments
Verastem Valued At Premium, InVivo Worth Even More On Innovative Therapy
on Fri, Feb 10, 2012 • VSTM, GERN, NVIV.OB • 1 Comment
Ampio Pharmaceuticals: Anti-Inflammatory Medicine Awaits FDA Guidance On Pivotal Juncture
on Tue, Jan 31, 2012 • CTIC, GERN, STEM • 4 Comments
Big Pharma, Take Note: Prolor Biotech's CTP Technology Yields Bio-Better Proteins
on Fri, Jan 20, 2012 • AMGN, LLY, MRK • 2 Comments
Interview: Ampio Pharmaceuticals' CEO Tackles 'Unanswered Questions'
on Tue, Dec 27, 2011 • JNJ, MRK, VRX • 15 Comments
Antares' Sell-Off Overdone
on Fri, Dec 16, 2011 • BPAX, ATRS • 4 Comments
Ampio Pharmaceuticals: Anywhere But Straight Out Of Isolagen's Playbook
on Wed, Dec 14, 2011 • AMPE • 31 Comments
NovaBay Pharmaceuticals: Galderma Partnership Suggests Untapped Value
on Fri, Dec 9, 2011 • NBY • 3 Comments
The Beneficiaries of Geron's Exit From Stem Cell Therapy
on Tue, Nov 15, 2011 • GERN, ASTM, STEM • 11 Comments
InVivo's Innovative Instigation In Spinal Cord Injury
on Fri, Nov 11, 2011 • ASTM, GERN, PSTI • 2 Comments
High Power International: 5 Reasons To Call It A Growth Story
on Thu, Nov 3, 2011 • HPJ • 1 Comment
Ampio's Zertane: A Multi-Purpose Drug Potentially Worth Multi-Billions
on Tue, Oct 18, 2011 • JNJ, PFE, BAYRY.PK • 2 Comments
Emerging Technologies In Brain Cancer Therapy
on Tue, Sep 20, 2011 • IMUC, CLDX, NWBO • 14 Comments
5 Healthcare Stocks To Consider
on Thu, Sep 1, 2011 • AIQ, MSTX, DNDN • 4 Comments
Ampio Provides a Healthcare Sector Opportunity Amid a Tantrum of Selling
on Thu, Aug 11, 2011 • AMPE, JNJ, PFE • 2 Comments
Adventrx Pharmaceuticals: Undervalued Based on Product Approval Potential
on Thu, Jul 21, 2011 • MSFT, MSTX • 9 Comments
Uplisting May Be Next For ImmunoCellular Therapeutics
on Fri, Jul 15, 2011 • PCYC, THLD, YMI • 8 Comments
ChromaDex: How an Insider Piqued My Interest
on Wed, Jul 6, 2011 • ENDP, CDXC.OB • Comment!
CytRx: Small Oncology Firm Offers Unique Exposure to Big Pharma Culture
on Tue, Jun 14, 2011 • CYTR • Comment!
ImmunoCellular Therapeutics Ramps Up Value Proposition With Recent Deals
on Tue, Jun 7, 2011 • IMUC, BMY, NVS • 3 Comments
Investing in Cancer Therapy? Consider Companies Engaged in Immunotherapy
on Wed, Jun 1, 2011 • DNDN, IMUC, CLDX • 3 Comments